<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>To elucidate the clinicopathologic features of non-Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (NHL) in Taiwan, 123 adult patients with proven NHL were studied </plain></SENT>
<SENT sid="1" pm="."><plain>They were classified according to the international working formulation as: low grade (LG), 12.2%; intermediate grade (IG), 42.3%; and high grade (HG) <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, 45.5% </plain></SENT>
<SENT sid="2" pm="."><plain>The most common subtypes were diffuse large cell (26.8%) and large cell <z:e sem="disease" ids="C1521815" disease_type="Neoplastic Process" abbrv="">immunoblastic</z:e> (26.8%) <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> accounted for only 8.9% (11 cases) </plain></SENT>
<SENT sid="4" pm="."><plain>Complete remission rates for LG, IG and HG <z:hpo ids='HP_0002665'>lymphomas</z:hpo> were 53%, 35% and 34%, respectively </plain></SENT>
<SENT sid="5" pm="."><plain>LG <z:hpo ids='HP_0002665'>lymphoma</z:hpo> had a significantly better survival than that of IG and HG <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>The IG <z:hpo ids='HP_0002665'>lymphoma</z:hpo> encompassed a <z:hpo ids='HP_0001425'>heterogeneous</z:hpo> group of patients with varying prognoses but the overall survival curve was indistinguishable from that of HG <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>Clinically, 66% of HG, 77% of IG and 86% of LG <z:hpo ids='HP_0002665'>lymphoma</z:hpo> presented with advanced disease </plain></SENT>
<SENT sid="8" pm="."><plain>LG <z:hpo ids='HP_0002665'>lymphoma</z:hpo> had high frequencies of <z:hpo ids='HP_0001433'>hepatosplenomegaly</z:hpo> (30-50%) and bone marrow involvement (53%), whereas skin, bone and central <z:mp ids='MP_0008912'>nervous</z:mp> system involvement occurred exclusively in IG and HG <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain>Mild <z:hpo ids='HP_0001903'>anemia</z:hpo> was common and occurred in 40-50% of the patients </plain></SENT>
<SENT sid="10" pm="."><plain><z:e sem="disease" ids="C0020455" disease_type="Disease or Syndrome" abbrv="">Hyperimmunoglobulinemia</z:e> was found in 50-60% of <z:hpo ids='HP_0000001'>all</z:hpo> 3 grades of <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, <z:e sem="disease" ids="C1136085" disease_type="Neoplastic Process" abbrv="">monoclonal gammopathy</z:e> in 3 cases of IG <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, and <z:hpo ids='HP_0003072'>hypercalcemia</z:hpo> in 4 cases of IG and HG <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
<SENT sid="11" pm="."><plain>Elevated serum <z:chebi fb="4" ids="24996">lactate</z:chebi> dehydrogenase occurred mainly in IG and HG <z:hpo ids='HP_0002665'>lymphomas</z:hpo> and was an important prognostic factor </plain></SENT>
<SENT sid="12" pm="."><plain>In conclusion, the characteristic features of NHL in Taiwan include: (1) a high proportion of HG <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and low proportions of LG and follicular <z:hpo ids='HP_0002665'>lymphomas</z:hpo>; (2) a <z:hpo ids='HP_0001425'>heterogeneous</z:hpo> patient composition of IG <z:hpo ids='HP_0002665'>lymphoma</z:hpo> with an unfavorable overall prognosis.(ABSTRACT TRUNCATED AT 250 WORDS) </plain></SENT>
</text></document>